Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Kaufman

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Psycho-Oncology|May 2, 2018
Incongruence between women's survey- and interview-determined decision control preferences: A mixed methods study of decision-making in metastatic breast cancerDeborah Ejem, J Nicholas Dionne-Odom, Yasemin Turkman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2026
Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women With HR+/HER2- Metastatic Breast CancerGregory A Vidal, Julie Katz, Natalia Sadetsky, et al.
Antioxidants & Redox Signaling|July 14, 2007
Developments in quantitative oxygen-saturation imaging of breast tissue in vivo using multispectral near-infrared tomographySubhadra Srinivasan, Brian W Pogue, Colin Carpenter, et al.
Breast Cancer : Basic and Clinical Research|July 12, 2016
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast CancerChris Twelves, Ahmad Awada, Javier Cortes, et al.
Proceedings of Spie--The International Society for Optical Engineering|January 4, 2014
Comparison of iron oxide nanoparticle and microwave hyperthermia alone or combined with cisplatinum in murine breast tumorsAlicia A Petryk, Robert V Stigliano, Andrew J Giustini, et al.
Breast Cancer Research and Treatment|April 8, 2014
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancerDenise A Yardley, Peter A Kaufman, Adam Brufsky, et al.
Current Treatment Options in Oncology|April 21, 2025
Cardio-Oncology and Breast Cancer TherapiesRohit Singh, Krina Patel, Haze Xu, et al.
Journal of Biomedical Optics|July 12, 2013
Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxideShudong Jiang, Brian W Pogue, Kelly E Michaelsen, et al.
The Oncologist|May 9, 2013
First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHERDebu Tripathy, Peter A Kaufman, Adam M Brufsky, et al.
Scientific Reports|January 27, 2026
Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancerNatalia Sadetsky, Patricia Prince, Helen Latimer, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Psycho-Oncology|May 2, 2018
Incongruence between women's survey- and interview-determined decision control preferences: A mixed methods study of decision-making in metastatic breast cancerDeborah Ejem, J Nicholas Dionne-Odom, Yasemin Turkman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 29, 2026
Sociodemographic Disparities in First-Line Treatment and Outcome Patterns in Women With HR+/HER2- Metastatic Breast CancerGregory A Vidal, Julie Katz, Natalia Sadetsky, et al.
Antioxidants & Redox Signaling|July 14, 2007
Developments in quantitative oxygen-saturation imaging of breast tissue in vivo using multispectral near-infrared tomographySubhadra Srinivasan, Brian W Pogue, Colin Carpenter, et al.
Breast Cancer : Basic and Clinical Research|July 12, 2016
Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast CancerChris Twelves, Ahmad Awada, Javier Cortes, et al.
Proceedings of Spie--The International Society for Optical Engineering|January 4, 2014
Comparison of iron oxide nanoparticle and microwave hyperthermia alone or combined with cisplatinum in murine breast tumorsAlicia A Petryk, Robert V Stigliano, Andrew J Giustini, et al.
Breast Cancer Research and Treatment|April 8, 2014
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancerDenise A Yardley, Peter A Kaufman, Adam Brufsky, et al.
Current Treatment Options in Oncology|April 21, 2025
Cardio-Oncology and Breast Cancer TherapiesRohit Singh, Krina Patel, Haze Xu, et al.
Journal of Biomedical Optics|July 12, 2013
Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxideShudong Jiang, Brian W Pogue, Kelly E Michaelsen, et al.
The Oncologist|May 9, 2013
First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHERDebu Tripathy, Peter A Kaufman, Adam M Brufsky, et al.
Scientific Reports|January 27, 2026
Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancerNatalia Sadetsky, Patricia Prince, Helen Latimer, et al.
Pageof 10